CN107320781A - Organization engineering skin containing living cells and preparation method thereof - Google Patents
Organization engineering skin containing living cells and preparation method thereof Download PDFInfo
- Publication number
- CN107320781A CN107320781A CN201710562163.2A CN201710562163A CN107320781A CN 107320781 A CN107320781 A CN 107320781A CN 201710562163 A CN201710562163 A CN 201710562163A CN 107320781 A CN107320781 A CN 107320781A
- Authority
- CN
- China
- Prior art keywords
- fibroblast
- culture
- epithelial cells
- dmem
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/222—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to tissue engineering technique field, specifically related to a kind of organization engineering skin containing living cells and preparation method thereof, the organization engineering skin includes epidermis, emulation cortex and skin corium, described emulation cortex includes epithelial cells, fibroblast and biologic bracket material, and wherein epithelial cells and fibroblastic density ratio are 0.1 0.2:1;Described biologic bracket material is by gelatin, chitosan, glutamine peptide and hyaluronic acid in mass ratio 67:1.5‑2:0.5‑1:1 composition, artificial skin produced by the present invention has a good biocompatibility, good plasticity and mechanical strength, can preferably wound repairing.
Description
Technical field
The invention belongs to tissue engineering technique field, and in particular to a kind of organization engineering skin containing living cells and its system
Preparation Method.
Background technology
Organizational engineering (tissueengineering) is one and is combined with cell biology, engineering science and materialogy,
Tissue or organ substitute are built in vitro or in vivo, and one for repairing, maintaining or improving body form and function is emerging
Cross discipline.Wherein organization engineering skin is to build artificial skin substitute using the principle of organizational project, is moved for skin
Plant, can effectively solve clinically defect of skin reparation, for the problem that skin is not enough.
Skin tissue engineering is to develop earliest, most ripe field in organizational engineering, and the first ratifies listing through FDA
Tissue engineering product is exactly organization engineering skin.Clinically the ulcer of skin ulcer including diabetes, veins intractable ulcer,
Ulcer etc. caused by pyoderma gangraenosum ulcer and some other diseases, conventional treatment method tends not to obtain satisfaction
Effect, and effect is notable after using artificial skin treatment.
At present, there are a variety of skin products to come out, and for clinical treatment, achieved certain curative effect, but deposit simultaneously
In some defects, such as poor compatibility, rejection, cultivation cycle is long, and bubble is easily formed after transplanting, scar contracture easily occurs,
Cause loss of moist etc. in skin, in order that organization engineering skin is more nearly human body skin, increasing research is entered to it
Innovation of having gone is improved.
Notification number discloses a kind of organization engineering skin construction method for CN102462864B Chinese patent, and this method is adopted
With human epidermal stem cell, dermal fibroblast as seed cell, with by the of the same race without thin of Human plactnta IV Collagen Type VIs modification
Born of the same parents' dermal matrix is configured to a kind of active double-layer tissue engineering skin as support using gas-liquid interface isolated culture is compound
Skin.The organization engineering skin that this method is built is closer to the structure of natural skin, and wherein dermal collagen supporting structure is complete, epidermis
There is the cell of the different differentiation degree of multilayer in layer, the morphology requirement of organization engineering skin is reached, but the invention culture medium
In add hyclone, easily occur rejection.
Publication No. CN104740689A Chinese patent application discloses a kind of composite tissue engineering skin containing living cells
Skin and preparation method thereof.The composite tissue engineering skin both contains living cells, and degradable polymeric material protective layer is contained again, is made
Obtain composite tissue engineering skin isolating power enhancing, cost reduction, extended shelf-life.Overcome in the prior art containing living thin
The organization engineering skin of born of the same parents is with high costs, and the shelf-life is short, the defect of isolating power difference.But used in the invention it is degradable
Polymeric material protective layer degradation time in human body is long, easily causes surface of a wound docile effect poor.
The content of the invention
In order to overcome the deficiencies in the prior art, the invention discloses a kind of organization engineering skin containing living cells and its preparation
Method, obtained artificial skin has good biocompatibility, and good plasticity and mechanical strength can be repaired preferably
The surface of a wound.
Concrete technical scheme of the present invention is as follows:
A kind of organization engineering skin containing living cells, including epidermis, emulation cortex and skin corium, described emulation cortex
Including epithelial cells, fibroblast and biologic bracket material, wherein epithelial cells and fibroblastic density ratio are 0.1-
0.2:1;Described biologic bracket material is by gelatin, chitosan, glutamine peptide and hyaluronic acid 6-7 in mass ratio:1.5-2:
0.5-1:1 composition.
The present invention adds emulation cortex between epidermis and skin corium, epidermis is contacted with emulation cortex and more steps up
Close, it is to avoid epidermis directly contacts the flaky shortcoming of appearance with skin corium, experiment proves that the angle protein contained in emulation cortex is thin
Born of the same parents are unordered with fibroblastic growth, can be effectively increased the toughness of organization engineering skin, improve wound healing effect;And this
Invent in the biologic bracket material used and add glutamine peptide, be conducive to it to decompose, and test discovery, add glutamine peptide
The toughness and elasticity of skin can be improved, apply be conducive in biologic bracket material improve its mechanical strength, glutamine peptide with
Human body has preferable compatibility, is conducive to organization engineering skin to have when using with the surface of a wound and carrys out good affinity, in addition, paddy acyl
Amine peptide can also supply nutrients for follow-up cell growth.
Further, the preparation method of described emulation cortex is:Under the conditions of 4 DEG C, by biologic bracket material and DMEM
Culture medium by volume 1:After 1 mixing, epithelical cell growth factor and Basic Fibroblast Growth Factor are added, fiber finer is inoculated with into
Born of the same parents and the mixed liquor of epithelial cells, two kinds of cell inoculation gross densities are 2 × 106/ ml, wherein epithelial cells with it is fibroblastic
Density ratio is 0.1-0.2:1,37 DEG C, 5%CO2Cultivated 4-5 days in incubator, be subsequently placed in culture dish and solidified, form imitative
Skin corium;
The amount ratio of described epithelical cell growth factor, Basic Fibroblast Growth Factor and DMEM culture mediums is 2-3ng:
12-15ng:1ml。
Further, described biologic bracket material by gelatin, chitosan, glutamine peptide and hyaluronic acid in mass ratio
6.5:1.75:0.75:1 composition.
Further, the preparation method of described biologic bracket material is:Under the conditions of 50 DEG C, gelatin is configured to quality
Fraction is 10% aqueous gelatin solution, and chitosan is dissolved in to be configured to mass fraction in the acetum that mass fraction is 2% be 2%
The acetum of chitosan, two kinds of solution are mixed, and add glutamine peptide and hyaluronic acid, are stirred, and stand 24-36 small
When, obtained mixed liquor is then prolonged into film forming for stream on 20 DEG C of horizontal polyvinyl chloride panel in surface temperature, is using pH finally
7.2-7.4 sodium hydroxide solutions soak 12 hours, dry, produce.
Further, present invention also offers the preparation method of the organization engineering skin containing living cells, step is:
(1) epithelial cells and fibroblast are obtained
(2) emulation cortex is prepared
Under the conditions of 4 DEG C, by biologic bracket material and DMEM culture mediums by volume 1:After 1 mixing, epidermal cell is added
The mixed liquor of growth factor and Basic Fibroblast Growth Factor, inoculation fibroblast and epithelial cells, two kinds of cell inoculations are total
Density is 2 × 106/ ml, wherein epithelial cells are 0.1-0.2 with fibroblastic density ratio:1,37 DEG C, 5%CO2In incubator
Culture 4-5 days, is subsequently placed in culture dish and is solidified, and forms emulation cortex;Described epithelical cell growth factor, alkalescence into
The amount ratio of fibroblast growth factor and DMEM culture mediums is 2-3ng:12-15ng:1ml;
(3) skin corium is prepared
Fibroblast is inoculated into the emulation cortical surface that step (2) is obtained, fibroblast culture medium, inoculation is added
Density is 1 × 106/ ml, 37 DEG C, 5%CO2Cultivated 1-3 days in incubator, obtain corium-emulation cortex;
(4) epidermis is prepared
Epithelial cells is inoculated into the emulation cortical surface for corium-emulation cortex that step (3) is obtained, epidermal cell is added
Culture medium, inoculum density is 1 × 106/ ml, 37 DEG C, 5%CO2Cultivated 6-8 days in incubator, obtain corium-emulation cortex-epidermis
Layer;
(5) organization engineering skin is built
The corium that step (4) is obtained-emulation cortex-epidermis is laid in the bottom of culture dish, adds and contains 1 × 10- 4In the DMEM culture mediums of mol/L calcium chloride, 37 DEG C, 5%CO2Cultivate 6-8 days, produce in incubator.
Further, present invention also offers obtain epithelial cells in step (1) to be with fibroblastic method:
Transcription factor OCT4, SOX2, KLF4 and C-MYC are imported into human urine cell, then using cell density as 1 × 106
It is seeded in multipotential stem cell inducing culture, 37 DEG C, 5%CO2Cultivated in incubator, liquid is changed daily, continuous culture 25-30 days,
Obtain induced multi-potent stem cell;By induced multi-potent stem cell using cell density as 1 × 106It is seeded in mescenchymal stem cell induction training
Support in base, 37 DEG C, 5%CO2Cultivated in incubator, change liquid within every 2 days, continuous culture 14-16 days obtains mescenchymal stem cell;
The acquisition amplification of epithelial cells:By mescenchymal stem cell with density 1 × 106It is seeded in epithelial cells inducing culture
Middle differentiation obtains epithelial cells, when epithelial cells length is to 80%, removes epithelial cells inducing culture, is cultivated using DMEM/F12
Liquid is cleaned, plus to obtain angle protein unicellular by DPBS digestion 5min, the 400r/min centrifugations 5min of the EDTA containing 0.5mM, then by angle protein
Unicellular to be inoculated in cultured epidermal cell base, inoculum density is 1 × 106/ ml, 37 DEG C, 5%CO2Cultivated in incubator, you can;
It is fibroblastic to obtain amplification:By mescenchymal stem cell with density 1 × 106It is seeded in fibroblast induction training
Support differentiation in base and obtain fibroblast, when fibroblast length is to 80%, removes fibroblast inducing culture, use
DMEM/F12 nutrient solutions are cleaned, plus DPBS digestion 5min, the 400r/min centrifugations 5min of the EDTA containing 0.5mM obtains into fiber list
Cell, then will be inoculated in fibroblast culture medium into fiber is unicellular, and inoculum density is 1 × 106/ ml, 37 DEG C, 5%
CO2Cultivated in incubator, you can.
Further, described cultured epidermal cell base is:The culture medium based on DMEM/F12, additive and consumption
For:The μ g/mL of bovine brain pituitary extract 50, hydrocortisone 5ng/mL, cholera toxin 1 × 10-10Mol/L, insulin 0.05ng/
ML, adenine 1.8 × 10-4Mol/L, penicillin 100IU/mL, the μ g/mL of transferrins 10, the μ g/mL of glutamic acid 5, epidermal cell life
The long μ g/mL of the factor 10, monoethanolamine 1 × 10-5mol/L;
Described fibroblast culture medium is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain is hung down
The μ g/mL of body extract 50, insulin 5ng/mL, the μ g/ml of hydrocortisone 300, the μ g/mL of adenine 15, the μ g/ of vitamin C 120
ML, the μ g/mL of Basic Fibroblast Growth Factor 8, the μ g/mL of transferrins 10;
Described epithelial cells inducing culture is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain
The μ g/mL of pituitary extract 50, penicillin 100IU/mL, the μ g/mL of streptomysin 100, epithelical cell growth factor 20ng/mL, pancreas islet
10 μ g/mL of element, the μ g/mL of vitamin A acid 8, the μ g/mL of calcium chloride 6;
Described fibroblast inducing culture is:The culture medium based on DMEM/F12, additive and consumption are:Ox
The μ g/mL of pituitary extract 50, penicillin 100IU/mL, the μ g/mL of streptomysin 100, transforming growth factor β l15ng/mL, alkalescence
FGF2 0ng/mL, the μ g/mL of pancreas islet plain sheet selenium transferrin 10,0.1 μm of ol/L of dexamethasone;
Described multipotential stem cell inducing culture is:The culture medium based on fibroblast culture medium, additive and
Consumption is:L-GLUTAMINE 2mmol/L, nonessential amino acid 0.02mmol/mL;
Described mescenchymal stem cell inducing culture is:The culture medium based on DMEM/F12, additive and consumption are:
The μ g/mL of bovine brain pituitary extract 50, l-GLUTAMINE 2mmol/L.
Described DMEM/F12 weight ratio is 2:1.
The epidermal cell culture base and corium culture medium used in the present invention is changed using the mixing of commercial DMEM and F12 culture mediums
Enter culture medium, F12 culture mediums contain various trace elements, and DMEM medium nutrient contents concentration is high, be allowed to be blended in addition ox
Pituitary extract, instead of traditional blood serum medium, reduces the content of antigen, reduces the infection of virus.
A kind of organization engineering skin structure containing living cells obtained by the present invention is corium-emulation cortex-epidermis, its
The random growth layer containing fibroblast and epithelial cells, epidermis is cultivated in emulation cortex both sides respectively in middle emulation cortex
With skin corium, the existing layer structure of organization engineering skin for obtaining culture is difficult layering and peeled off, improves organization engineering skin again
Mechanical strength, and bovine brain pituitary extract present in fibroblast after transplanting in skin corium and culture medium can promote
Enter wound healing, the various growth factors of secretion can accelerate surface of a wound cell and fibroblastic intergrowth, with good
Compatibility, wound healing time is short, in addition, the biologic bracket material that the present invention is used can not only protect the surface of a wound not by the external world
Pollution, and with good biodegradability.
Compared with prior art:Instant invention overcomes the skin corium of individual layer living cell tissue engineering skin in the prior art appearance
Easily by extraneous bacterium infection, and the shortcoming of water holding capacity difference, it is with high costs also to compensate for double-deck living cell tissue's engineering skin,
Poor compatibility, biologic bracket material is difficult the shortcoming absorbed, and makes skin mechanical performance the invention belongs to three layers of skin texture
It is stronger.
Embodiment
The present invention is further detailed below by embodiment.The composition that the present invention is used belongs to conventional production
Product, wherein, chitosan:CAS.148411-57-8, is purchased from big magnificent great achievement medication chemistry (group) Co., Ltd in Wuhan;DMEM、
F12:Upper Asteriidae bio tech ltd;Bovine brain pituitary extract:BPE brands:ScienCell, article No. 0713;Pancreas islet
Element:CAS:11061-68-0, Hubei Xin Kang medication chemistries Co., Ltd.
The kinds of culture medium of embodiment 1 and composition
A kind of cultured epidermal cell base is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain hypophysis is carried
Take the μ g/mL of thing 50, hydrocortisone 5ng/mL, cholera toxin 1 × 10-10Mol/L, insulin 0.05ng/mL, adenine 1.8 ×
10-4Mol/L, penicillin 100IU/mL, the μ g/mL of transferrins 10, the μ g/mL of glutamic acid 5, the μ g/mL of epithelical cell growth factor 10,
Monoethanolamine 1 × 10-5mol/L;
A kind of fibroblast culture medium is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain hypophysis
The μ g/mL of extract 50, insulin 5ng/mL, the μ g/ml of hydrocortisone 300, the μ g/mL of adenine 15, the μ g/mL of vitamin C 120,
The μ g/mL of Basic Fibroblast Growth Factor 8, the μ g/mL of transferrins 10;
A kind of epithelial cells inducing culture is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain is hung down
The μ g/mL of body extract 50, penicillin 100IU/mL, the μ g/mL of streptomysin 100, epithelical cell growth factor 20ng/mL, insulin
10 μ g/mL, the μ g/mL of vitamin A acid 8, the μ g/mL of calcium chloride 6;
A kind of fibroblast inducing culture is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain
The μ g/mL of pituitary extract 50, penicillin 100IU/mL, the μ g/mL of streptomysin 100, transforming growth factor β l15ng/mL, alkalescence into
Fibroblast growth factor 20ng/mL, the μ g/mL of pancreas islet plain sheet selenium transferrin 10,0.1 μm of ol/L of dexamethasone;
A kind of multipotential stem cell inducing culture is:The culture medium based on fibroblast culture medium, additive and use
Measure and be:L-GLUTAMINE 2mmol/L, nonessential amino acid 0.02mmol/mL;
A kind of mescenchymal stem cell inducing culture is:The culture medium based on DMEM/F12, additive and consumption are:Ox
The μ g/mL of pituitary extract 50, l-GLUTAMINE 2mmol/L;
Described DMEM/F12 weight ratio is 2:1.
A kind of organization engineering skin containing living cells of embodiment 2
The described organization engineering skin containing living cells includes epidermis, emulation cortex and skin corium, described artificial leather
Layer includes epithelial cells, fibroblast and biologic bracket material, and wherein epithelial cells is with fibroblastic density ratio
0.15:1;Described biologic bracket material is by gelatin, chitosan, glutamine peptide and hyaluronic acid in mass ratio 6.5:1.75:
0.75:1 constitutes, and its preparation method is:Under the conditions of 50 DEG C, gelatin is configured to mass fraction for 10% aqueous gelatin solution, will
Chitosan is dissolved in the acetum for being configured to that mass fraction is 2% chitosan in the acetum that mass fraction is 2%, by two kinds
Solution is mixed, and adds glutamine peptide and hyaluronic acid, is stirred, and 30 hours is stood, then by obtained mixed liquor in table
Face temperature prolongs film forming for 20 DEG C of horizontal polyvinyl chloride panel upstream, the use of pH is finally that 7.3 sodium hydroxide solutions soak 12 hours,
Dry, produce;
The preparation method of the described organization engineering skin containing living cells,
(1) epithelial cells and fibroblast are obtained
Concretely comprise the following steps:Transcription factor OCT4, SOX2, KLF4 and C-MYC are imported into human urine cell, it is then close with cell
Spend for 1 × 106It is seeded in multipotential stem cell inducing culture, 37 DEG C, 5%CO2Cultivated in incubator, liquid is changed daily, continuous culture
27 days, obtain induced multi-potent stem cell;By induced multi-potent stem cell using cell density as 1 × 106It is seeded in mescenchymal stem cell
In inducing culture, 37 DEG C, 5%CO2Cultivated in incubator, change liquid within every 2 days, continuous culture 15 days obtains mescenchymal stem cell;
The acquisition amplification of epithelial cells:By mescenchymal stem cell with density 1 × 106It is seeded in epithelial cells inducing culture
Middle differentiation obtains epithelial cells, when epithelial cells length is to 80%, removes epithelial cells inducing culture, is cultivated using DMEM/F12
Liquid is cleaned, plus to obtain angle protein unicellular by DPBS digestion 5min, the 400r/min centrifugations 5min of the EDTA containing 0.5mM, then by angle protein
Unicellular to be inoculated in cultured epidermal cell base, inoculum density is 1 × 106/ ml, 37 DEG C, 5%CO2Cultivated in incubator, you can;
It is fibroblastic to obtain amplification:By mescenchymal stem cell with density 1 × 106It is seeded in fibroblast induction training
Support differentiation in base and obtain fibroblast, when fibroblast length is to 80%, removes fibroblast inducing culture, use
DMEM/F12 nutrient solutions are cleaned, plus DPBS digestion 5min, the 400r/min centrifugations 5min of the EDTA containing 0.5mM obtains into fiber list
Cell, then will be inoculated in fibroblast culture medium into fiber is unicellular, and inoculum density is 1 × 106/ ml, 37 DEG C, 5%
CO2Cultivated in incubator, you can.
(2) emulation cortex is prepared
Under the conditions of 4 DEG C, by biologic bracket material and DMEM culture mediums by volume 1:After 1 mixing, epidermal cell is added
The mixed liquor of growth factor and Basic Fibroblast Growth Factor, inoculation fibroblast and epithelial cells, two kinds of cell inoculations are total
Density is 2 × 106/ ml, wherein epithelial cells are 0.15 with fibroblastic density ratio:1,37 DEG C, 5%CO2Cultivated in incubator
4.5 days, it is subsequently placed in culture dish and is solidified, forms emulation cortex;Described epithelical cell growth factor, basic fibroblast
The amount ratio of growth factor and DMEM culture mediums is 2.5ng:13.5ng:1ml;
(3) skin corium is prepared
Fibroblast is inoculated into the emulation cortical surface that step (2) is obtained, fibroblast culture medium, inoculation is added
Density is 1 × 106/ ml, 37 DEG C, 5%CO2Cultivated 2 days in incubator, obtain corium-emulation cortex;(4) epidermis is prepared
Epithelial cells is inoculated into the emulation cortical surface for corium-emulation cortex that step (3) is obtained, epidermal cell is added
Culture medium, inoculum density is 1 × 106/ ml, 37 DEG C, 5%CO2Cultivated 7 days in incubator, obtain corium-emulation cortex-epidermis;
(5) organization engineering skin is built
The corium that step (4) is obtained-emulation cortex-epidermis is laid in the bottom of culture dish, adds and contains 1 × 10- 4In the DMEM culture mediums of mol/L calcium chloride, 37 DEG C, 5%CO2Cultivate 7 days, produce in incubator.
The culture medium that embodiment 2 is related to uses the formula that embodiment 1 is provided
A kind of organization engineering skin containing living cells of embodiment 3
Difference with embodiment 2 is that described biologic bracket material is by gelatin, chitosan, glutamine peptide and hyaluronic acid
In mass ratio 6:2:1:1 composition, other be the same as Examples 2.
A kind of organization engineering skin containing living cells of embodiment 4
Difference with embodiment 2 is that described biologic bracket material is by gelatin, chitosan, glutamine peptide and hyaluronic acid
In mass ratio 7:1.5:0.5:1 composition, other be the same as Examples 2.
A kind of organization engineering skin containing living cells of comparative example 1
Difference with embodiment 2 is, glutamine peptide is replaced using fibrin, described biologic bracket material by gelatin,
Chitosan, fibrin and hyaluronic acid in mass ratio 6.5:1.75:0.75:1 composition, other be the same as Examples 2.
A kind of organization engineering skin containing living cells of comparative example 2
Difference with embodiment 2 is, without the step of emulating cortex is prepared in preparation method, to use biologic bracket material
Instead of emulating cortex, obtained organization engineering skin is corium-biologic bracket material-epidermis, other be the same as Examples 2.
The assay of the living cells of test example 1
Using mtt assay to the living cells content in 2-4 of the embodiment of the present invention and organization engineering skin made from comparative example 1-2
It is measured, obtained organization engineering skin is preserved after 15 days and 40 days respectively, living cells content is determined respectively.
Test method:By 1mm2The skin of area is cut into small pieces, and is put into nutrient solution, and addition MTT (concentration 5mg/ml, often
106Cell 200ul) be incubated 4 hours under the conditions of 37 DEG C, discard nutrient solution, the skin after the completion of incubation shredded, add DMSO in
Lower 100 revs/min of normal temperature shakes 20 minutes, the supernatant extraction after concussion is put its OD value is determined under ELIASA;
Same method determines the OD values with contained living cells in homalographic;
Living cells content=skin OD values/living cells OD value × 100%, it is specific as shown in table 1.
The activity of living cells result of table 1
Embodiment 2 | Embodiment 3 | Embodiment 4 | Comparative example 1 | Comparative example 2 | |
After 20 days | 85% | 83% | 82% | 72% | 68 |
After 40 days | 61% | 58% | 56% | 45% | 43% |
From table 1 it follows that organization engineering skin made from embodiment 2-4 is after preserving 20 days, living cells content is protected
Hold more than 82%, after preserving 40 days, living cells content is maintained at more than 56%, and organizational project skin made from comparative example 1-2
The content that skin preserves living cells after same time is greatly reduced, and illustrates the organization engineering skin storage life of the invention provided more
Long, glutamine peptide influences the cell of organization engineering skin in the preparation of further clear artificial leather layer and biologic bracket material
Activity.
The animal implant tests textured of test example 2
Test material:Male Balb/c-nu mouse (nude mice, the western pul-Bi Kai experimental animals Co., Ltd in Shanghai provides),
20 ± 1 grams, 30 of body weight.
Test method:Pretreatment:Nude mice shaves skin of back hair, in mouse after chloraldurate intraperitoneal injection of anesthesia
In the median line of back, the circular skin holostrome of an a diameter of 6mm is removed with operating scissors, lesion thickness is uniform;
(1) transplant:2-4 of the embodiment of the present invention and organization engineering skin made from comparative example 1-2 are transplanted in the surface of a wound, set
Positive controls:Normal healing, is fixed organization engineering skin, Sterilized application covers after transplanting using intradermal suturing skill
Lid;
(2) post surgery treatment:All mouse carry out single cage nursing under identical condition, and surface of a wound situation is observed after transplanting.Tool
Body result is as shown in table 2:
The healing time of table 2
Embodiment 2 | Embodiment 3 | Embodiment 4 | Comparative example 1 | Comparative example 2 | Control group | |
Heal area (1 week) | 69% | 65% | 67% | 49% | 46% | 32% |
Heal area (2 weeks) | 100% | 99% | 99% | 91% | 90% | 80% |
Complete healing time/day | 14 | 14.5 | 15 | 18 | 19 | 23 |
From Table 2, it can be seen that embodiment 1-3 compares comparative example 1-2 and control group, healing rate faster, and passes through
Transplant experiment observation is found:Control group:Surface of a wound crust is relatively thin, and color is dark red, and healing rate is slow, easily occurs breakage, is cured completely
After conjunction, crust is to lower recess, and skin is tight, and gently touching neoplastic skin does not have any elasticity.
Comparative example 1-2:The surface of a wound and organization engineering skin stick that effect is good, and blister is produced, and crust is slightly elastic, gently touches
Touch neoplastic skin slightly more tight than normal skin.
Embodiment 2-4:The surface of a wound and organization engineering skin stick that effect is good, and blister is produced, and surface of a wound skin becomes flexible,
Gently touch neoplastic skin tight, it is identical with normal skin sense of touch.
Transplant after 4 weeks, sections observation discovery is carried out to surface of a wound skin, work is organized using made from 2-4 of the embodiment of the present invention
Epidermis and dermis physically well develop after journey dermatoplasty, and form uses comparative example 1 is obtained to organize close to normal skin
Healing rate is slow after engineering skin transplanting, and skin holostrome structure is relatively thin relative to normal skin, is organized using comparative example 2 is obtained
Skin holostrome structure is thicker relative to normal skin after engineering skin transplanting, illustrates that organizational project can be caused by lacking emulation cortex
Skin Cell hyperplasia.
The elasticity of test example 3 and toughness test
Subjects:The surface of a wound skin obtained after being transplanted 4 weeks using the specimen method described in test example 2;
Specimen method:The square surface of a wound skins of 5 × 5mm are taken, skin both sides is forced in, calculates the elasticity and toughness of skin,
Toughness:The power that skin applies when broken;Elasticity:Deformation (length change) size when skin is broken;Concrete outcome is as shown in table 3.
The skin elasticity of table 3 and toughness data result
From table 3 it is observed that the organization engineering skin that embodiment 2-4 is prepared has bigger elasticity and toughness,
And comparative example 1-2 toughness and elasticity are slightly worse, control group is normal healing, and its internal hetero-organization or angiogenic growth speed are slow, and
And because healing time is long, atrophy directly occurs for the surface of a wound, cause surface of a wound skin degradation.
The above-described embodiments merely illustrate the principles and effects of the present invention, not for the limitation present invention.It is any ripe
Know the personage of this technology all can carry out modifications and changes under the spirit and scope without prejudice to the present invention to above-described embodiment.Cause
This, those of ordinary skill in the art is complete without departing from disclosed spirit and institute under technological thought such as
Into all equivalent modifications or change, should by the present invention claim be covered.
Claims (7)
1. a kind of organization engineering skin containing living cells, it is characterised in that described including epidermis, emulation cortex and skin corium
Emulation cortex include epithelial cells, fibroblast and biologic bracket material, wherein epithelial cells with it is fibroblastic close
Degree is than being 0.1-0.2:1;Described biologic bracket material is by gelatin, chitosan, glutamine peptide and hyaluronic acid 6- in mass ratio
7:1.5-2:0.5-1:1 composition.
2. the organization engineering skin as claimed in claim 1 containing living cells, it is characterised in that the preparation of described emulation cortex
Method is:Under the conditions of 4 DEG C, by biologic bracket material and DMEM culture mediums by volume 1:After 1 mixing, epidermal cell life is added
The mixed liquor of the long factor and Basic Fibroblast Growth Factor, inoculation fibroblast and epithelial cells, two kinds of cell inoculations are total close
Spend for 2 × 106/ ml, wherein epithelial cells are 0.1-0.2 with fibroblastic density ratio:1,37 DEG C, 5%CO2Trained in incubator
Support 4-5 days, be subsequently placed in culture dish and solidified, form emulation cortex;Described epithelical cell growth factor, alkalescence are into fibre
The amount ratio for tieing up growth factor and DMEM culture mediums is 2-3ng:12-15ng:1ml.
3. the organization engineering skin containing living cells as claimed in claim 1, it is characterised in that described biologic bracket material by
Gelatin, chitosan, glutamine peptide and hyaluronic acid in mass ratio 6.5:1.75:0.75:1 composition.
4. the organization engineering skin containing living cells as described in claim 1 or 3, it is characterised in that described biological support material
The preparation method of material is:Under the conditions of 50 DEG C, gelatin is configured to mass fraction for 10% aqueous gelatin solution, chitosan is dissolved in
The acetum that mass fraction is 2% chitosan is configured in the acetum that mass fraction is 2%, two kinds of solution are mixed,
And glutamine peptide and hyaluronic acid are added, stir, 24-36 hours are stood, then by obtained mixed liquor in surface temperature
Prolong film forming for 20 DEG C of horizontal polyvinyl chloride panel upstream, the use of pH is finally that 7.2-7.4 sodium hydroxide solutions soak 12 hours, dries in the air
It is dry, produce.
5. the preparation method of the organization engineering skin containing living cells as described in claim any one of 1-4, it is characterised in that step
Suddenly it is:
(1) epithelial cells and fibroblast are obtained
(2) emulation cortex is prepared
Under the conditions of 4 DEG C, by biologic bracket material and DMEM culture mediums by volume 1:After 1 mixing, epidermal growth is added
The mixed liquor of the factor and Basic Fibroblast Growth Factor, inoculation fibroblast and epithelial cells, two kinds of cells are inoculated with gross density
For 2 × 106/ ml, wherein epithelial cells are 0.1-0.2 with fibroblastic density ratio:1,37 DEG C, 5%CO2Cultivated in incubator
4-5 days, it is subsequently placed in culture dish and is solidified, forms emulation cortex;Described epithelical cell growth factor, basic fibroblast
The amount ratio of growth factor and DMEM culture mediums is 2-3ng:12-15ng:1ml;
(3) skin corium is prepared
Fibroblast is inoculated into the emulation cortical surface that step (2) is obtained, fibroblast culture medium, inoculum density is added
For 1 × 106/ ml, 37 DEG C, 5%CO2Cultivated 1-3 days in incubator, obtain corium-emulation cortex;
(4) epidermis is prepared
Epithelial cells is inoculated into the emulation cortical surface for corium-emulation cortex that step (3) is obtained, cultured epidermal cell is added
Base, inoculum density is 1 × 106/ ml, 37 DEG C, 5%CO2Cultivated 6-8 days in incubator, obtain corium-emulation cortex-epidermis;
(5) organization engineering skin is built
The corium that step (4) is obtained-emulation cortex-epidermis is laid in the bottom of culture dish, adds and contains 1 × 10-4Mol/L chlorine
In the DMEM culture mediums for changing calcium, 37 DEG C, 5%CO2Cultivate 6-8 days, produce in incubator.
6. the preparation method of the organization engineering skin as claimed in claim 5 containing living cells, it is characterised in that described step
(1) epithelial cells is obtained in is with fibroblastic method:
Transcription factor OCT4, SOX2, KLF4 and C-MYC are imported into human urine cell, then using cell density as 1 × 106It is seeded in
In multipotential stem cell inducing culture, 37 DEG C, 5%CO2Cultivated in incubator, liquid is changed daily, continuous culture 25-30 days is lured
Lead multipotential stem cell;By induced multi-potent stem cell using cell density as 1 × 106It is seeded in mescenchymal stem cell inducing culture
In, 37 DEG C, 5%CO2Cultivated in incubator, change liquid within every 2 days, continuous culture 14-16 days obtains mescenchymal stem cell;
The acquisition amplification of epithelial cells:By mescenchymal stem cell with density 1 × 106It is seeded in epithelial cells inducing culture and divides
Change obtains epithelial cells, when epithelial cells length is to 80%, removes epithelial cells inducing culture, clear using DMEM/F12 nutrient solutions
Wash, plus to obtain angle protein unicellular by DPBS digestion 5min, the 400r/min centrifugations 5min of the EDTA containing 0.5mM, it is then that angle protein is slender
Born of the same parents are inoculated in cultured epidermal cell base, and inoculum density is 1 × 106/ ml, 37 DEG C, 5%CO2Cultivated in incubator, you can;
It is fibroblastic to obtain amplification:By mescenchymal stem cell with density 1 × 106It is seeded in fibroblast inducing culture
Middle differentiation obtains fibroblast, when fibroblast length is to 80%, removes fibroblast inducing culture, uses DMEM/
F12 nutrient solutions are cleaned, plus to obtain into fiber unicellular by DPBS digestion 5min, the 400r/min centrifugations 5min of the EDTA containing 0.5mM,
Then it will be inoculated in into fiber is unicellular in fibroblast culture medium, inoculum density is 1 × 106/ ml, 37 DEG C, 5%CO2Incubator
Middle culture, you can.
7. the preparation method of the organization engineering skin containing living cells as described in claim 5 or 6, it is characterised in that
Described cultured epidermal cell base is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain hypophysis is extracted
The μ g/mL of thing 50, hydrocortisone 5ng/mL, cholera toxin 1 × 10-10Mol/L, insulin 0.05ng/mL, adenine 1.8 ×
10-4Mol/L, penicillin 100IU/mL, the μ g/mL of transferrins 10, the μ g/mL of glutamic acid 5, the μ g/mL of epithelical cell growth factor 10,
Monoethanolamine 1 × 10-5mol/L;
Described fibroblast culture medium is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain hypophysis is carried
Take the μ g/mL of thing 50, insulin 5ng/mL, the μ g/ml of hydrocortisone 300, the μ g/mL of adenine 15, the μ g/mL of vitamin C 120, alkali
Property fibroblast growth factor 8 μ g/mL, the μ g/mL of transferrins 10;
Described epithelial cells inducing culture is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain hypophysis
The μ g/mL of extract 50, penicillin 100IU/mL, the μ g/mL of streptomysin 100, epithelical cell growth factor 20ng/mL, the μ of insulin 10
G/mL, the μ g/mL of vitamin A acid 8, the μ g/mL of calcium chloride 6;
Described fibroblast inducing culture is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain is hung down
The μ g/mL of body extract 50, penicillin 100IU/mL, the μ g/mL of streptomysin 100, transforming growth factor β l15ng/mL, alkalescence are into fibre
Tie up Porcine HGF 20ng/mL, the μ g/mL of pancreas islet plain sheet selenium transferrin 10,0.1 μm of ol/L of dexamethasone;
Described multipotential stem cell inducing culture is:The culture medium based on fibroblast culture medium, additive and consumption
For:L-GLUTAMINE 2mmol/L, nonessential amino acid 0.02mmol/mL;
Described mescenchymal stem cell inducing culture is:The culture medium based on DMEM/F12, additive and consumption are:Bovine brain
The μ g/mL of pituitary extract 50, l-GLUTAMINE 2mmol/L;
Described DMEM/F12 weight ratio is 2:1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710562163.2A CN107320781B (en) | 2017-07-11 | 2017-07-11 | Tissue engineering skin containing living cells and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710562163.2A CN107320781B (en) | 2017-07-11 | 2017-07-11 | Tissue engineering skin containing living cells and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107320781A true CN107320781A (en) | 2017-11-07 |
CN107320781B CN107320781B (en) | 2020-03-10 |
Family
ID=60196577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710562163.2A Active CN107320781B (en) | 2017-07-11 | 2017-07-11 | Tissue engineering skin containing living cells and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107320781B (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0285471A1 (en) * | 1987-03-26 | 1988-10-05 | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA Groupement d'Intérêt Economique dit: | Method for obtaining a skin equivalent and so obtained skin equivalent |
JPH06292568A (en) * | 1993-04-06 | 1994-10-21 | Gunze Ltd | Method for culturing tissue and culture substrate used therefor |
CN1310027A (en) * | 2001-02-06 | 2001-08-29 | 中国人民解放军第三军医大学第三附属医院 | Preparation of compound artificial skin |
CN1468634A (en) * | 2002-07-15 | 2004-01-21 | 上海组织工程研究与开发中心 | Double-layered artificial skin and its prepn process |
US20040162615A1 (en) * | 1999-08-02 | 2004-08-19 | Ping Lam | Material and method for engraftment of a composite biocompatible skin graft on the neodermis of artificial skin |
CN101954124A (en) * | 2010-08-31 | 2011-01-26 | 中国人民解放军第二军医大学 | Tissue engineered skin with basilar membrane and construction method thereof |
CN101985052A (en) * | 2010-08-31 | 2011-03-16 | 中国人民解放军第二军医大学 | Skin substitute for automatically capturing endothelial progenitor cells and promoting vascularization and construction method thereof |
CN105169494A (en) * | 2015-07-13 | 2015-12-23 | 江南大学 | Tissue engineering skin preparation method |
-
2017
- 2017-07-11 CN CN201710562163.2A patent/CN107320781B/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0285471A1 (en) * | 1987-03-26 | 1988-10-05 | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA - CIRD GALDERMA Groupement d'Intérêt Economique dit: | Method for obtaining a skin equivalent and so obtained skin equivalent |
JPH06292568A (en) * | 1993-04-06 | 1994-10-21 | Gunze Ltd | Method for culturing tissue and culture substrate used therefor |
US20040162615A1 (en) * | 1999-08-02 | 2004-08-19 | Ping Lam | Material and method for engraftment of a composite biocompatible skin graft on the neodermis of artificial skin |
CN1310027A (en) * | 2001-02-06 | 2001-08-29 | 中国人民解放军第三军医大学第三附属医院 | Preparation of compound artificial skin |
CN1468634A (en) * | 2002-07-15 | 2004-01-21 | 上海组织工程研究与开发中心 | Double-layered artificial skin and its prepn process |
CN101954124A (en) * | 2010-08-31 | 2011-01-26 | 中国人民解放军第二军医大学 | Tissue engineered skin with basilar membrane and construction method thereof |
CN101985052A (en) * | 2010-08-31 | 2011-03-16 | 中国人民解放军第二军医大学 | Skin substitute for automatically capturing endothelial progenitor cells and promoting vascularization and construction method thereof |
CN105169494A (en) * | 2015-07-13 | 2015-12-23 | 江南大学 | Tissue engineering skin preparation method |
Also Published As
Publication number | Publication date |
---|---|
CN107320781B (en) | 2020-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fu et al. | Skin tissue repair materials from bacterial cellulose by a multilayer fermentation method | |
Jones et al. | A guide to biological skin substitutes | |
CN101302486B (en) | Acetobacter xylinum and method for preparing nano-cellulose skin tissue repair material by using the same | |
CN101925675A (en) | Bioengineered tissue constructs and methods for production and use | |
CN104726406B (en) | It is a kind of to induce the method that dental pulp Derived from Mesenchymal Stem Cells is nerve cell | |
CN101366976A (en) | Humanized heterogenous cell epimatrix material and preparation method thereof | |
CN106754668A (en) | A kind of stem cell medium and parenteral solution | |
CN105079783B (en) | Pharmaceutical composition and its preparation method and application | |
CN101914495A (en) | Culture method for largely amplifying hair follicle stem cells in vitro | |
CN101757691A (en) | Preparation method of tissue engineering cornea | |
CN108057116A (en) | Application of the stem cell composition in skin injury medicine | |
CN102086451A (en) | Method for amplifying seed cells of skin tissue engineering | |
CN105820998A (en) | Isolation extraction and culture method for human adipose-derived stem cells (ADSCs) for clinical back-transfusion grade cell therapy | |
CN105013013A (en) | Preparation method of skin ulcer repairing matrix | |
CN101597593B (en) | Method for culturing autologous tissue fibroblast | |
CN104292497A (en) | Preparation method of recombinant human collagen bio-sponge | |
CN104611289A (en) | Method for simultaneously preparing autologous epidermal cells and fibroblasts, and biological beauty product comprising autologous epidermal cells and fibroblasts | |
CN108066750A (en) | Stem cell and its secretion are used to treat the new application of skin burn | |
CN109112101A (en) | A kind of fibroblast culture medium and its application | |
CN108126246A (en) | Artificial skin construction method based on compound stem cell | |
CN110331127A (en) | A kind of preparation method of organizational project Skin scar model | |
CN100462059C (en) | Method for preparing artificial skin used for reparing skin defect | |
CN108066824A (en) | A kind of new method for preparing skin blemish medicine | |
CN107320781A (en) | Organization engineering skin containing living cells and preparation method thereof | |
CN102552323A (en) | Medicine for accelerating skin repair and regeneration, preparation method thereof and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |